Showing results (171-180 of 265) with videos related to

Sort By:
Pageof 27
Thrombosis and Haemostasis|September 23, 2016
Global Anticoagulant Registry in the Field - Venous Thromboembolism (GARFIELD-VTE). Rationale and designJeffrey I Weitz, Sylvia Haas, Walter Ageno, et al.
Clinical and Experimental Nephrology|April 20, 2024
Effects of empagliflozin in patients with chronic kidney disease from Japan: exploratory analyses from EMPA-KIDNEYMasaomi Nangaku, William G Herrington, Shinya Goto, et al.
Research and Practice in Thrombosis and Haemostasis|March 18, 2021
Provoked versus unprovoked venous thromboembolism: Findings from GARFIELD-VTEWalter Ageno, Alfredo Farjat, Sylvia Haas, et al.
Thrombosis Research|May 23, 2021
The influence of anemia on clinical outcomes in venous thromboembolism: Results from GARFIELD-VTEShinya Goto, Alexander G G Turpie, Alfredo E Farjat, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|February 1, 2018
Antithrombotic therapy use and clinical outcomes following thrombo-embolic events in patients with atrial fibrillation: insights from ARISTOTLEShinya Goto, Peter Merrill, Lars Wallentin, et al.
JAMA Network Open|October 28, 2020
Assessment of Outcomes Among Patients With Venous Thromboembolism With and Without Chronic Kidney DiseaseShinya Goto, Sylvia Haas, Walter Ageno, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 21, 2019
The association between patterns of atrial fibrillation, anticoagulation, and cardiovascular eventsDan Atar, Eivind Berge, Jean-Yves Le Heuzey, et al.
Thrombosis Research|May 19, 2020
Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTEHenri Bounameaux, Sylvia Haas, Alfredo E Farjat, et al.
Pageof 27